MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$50,430K
(74.82%↑ Y/Y)
Net loss
-$50,341K
(74.88%↑ Y/Y)
Unrealized (loss) gain on
investments
-$89K
(-201.14%↓ Y/Y)
Interest income and other
$6,909K
(-43.80%↓ Y/Y)
Net product
revenue-License
$45,000K
Net product
revenue-Product
$4,647K
Royalties and other
revenue
$156K
(95.00%↑ Y/Y)
Loss from operations
-$48,911K
(75.19%↑ Y/Y)
Interest and other
expense
$8,339K
(-46.47%↓ Y/Y)
Total revenues
$49,803K
(60.24%↑ Y/Y)
Total operating
expenses
$98,714K
(-56.74%↓ Y/Y)
Research and development
$61,121K
(-27.65%↓ Y/Y)
Selling, general and
administrative expense
$37,319K
(-73.92%↓ Y/Y)
Cost of sales
$274K
(-55.52%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)